Design, synthesis and evaluation of cytotoxic properties of bisamino glucosylated antitumor ether lipids against cancer cells and cancer stem cells12. Issue 11 (19th August 2016)

• Record Type: Journal Article
• Authors: Ogunsina, Makanjuola; Samadder, Pranati; Idowu, Temilolu; Arthur, Gilbert; Schweizer, Frank
• Is Part Of: MedChemComm. Volume 7:Issue 11(2016:Nov.)
• Page Start: 2100
• Page End: 2110
• Publication Date: 2016-08-19
• Subjects: Pharmaceutical chemistry -- Periodicals; 615.19
• DOI: 10.1039/c6md00328a
• Languages: English
• ISSNs: 2040-2503

Abstract

Abstract : Glycosylated antitumor ether lipids (GAELs) are a class of amphiphilic antitumor agents that kill cancer cells by a non-apoptotic pathway. Abstract : Glycosylated antitumor ether lipids (GAELs) are a class of amphiphilic antitumor agents that kill cancer cells by a non-apoptotic pathway. Previous studies have shown that 2-amino-2-deoxy-d - gluco -based GAELs such asα-GLN andβ-GLN show greatly improved antitumor activity against epithelial cancer cells and stem cells. To further optimize the bioactivity, we prepared a series of diamino-d - gluco -based GAELs and their analogs, and screened them against a panel of human epithelial cancer cell lines and cancer stem cells. Most of the new GAEL analogs are more potent than chlorambucil, cisplatin and salinomycin. The most potent bisamine-based GAEL analogs1, 2, 4 and8 showed 2- to 3-fold enhanced cytotoxicity against various cancer cell lines when compared toβ-GLN, indicating that the addition of a second amino group enhances the cytotoxic effect. The effect of the most active dicationic GAELs1 and4 on cancer stem cells isolated from breast (BT-474) and prostate (DU-145) cell lines revealed that the two GAELs inhibited the formation of tumor spheres and resulted in >95% loss of viability of the cancer stem cells at 5 μM. Activity of GAEL1 against BT-474 cancer stem cells is superior to that of salinomycin.